Summary of Key Points Core Viewpoint - Tianchen Medical (688013) has shown a positive stock performance, with a recent closing price of 38.71 yuan, reflecting a 4.85% increase from the previous week, and reaching a near one-year high of 39.0 yuan during trading [1] Company Announcements - As of July 31, 2025, Tianchen Medical has repurchased a total of 2,505,324 shares, with a total expenditure of approximately 42.5 million yuan [1] - The company announced a share repurchase plan on December 27, 2023, with a total repurchase amount set between 18 million and 36 million yuan, at a maximum price of 30 yuan per share, over a 12-month period [1] - The repurchase amount was subsequently increased to between 36 million and 72 million yuan on July 9, 2024, and further adjusted to between 46 million and 80 million yuan on December 25, 2024, with the repurchase period extended to December 26, 2025 [1] - On January 6, 2025, the source of funds for the repurchase was adjusted to include the company's own funds and a special loan from CITIC Bank, not exceeding 34.65 million yuan [1] - The highest repurchase price recorded was 21 yuan per share, while the lowest was 11.87 yuan per share [1]
每周股票复盘:天臣医疗(688013)累计回购股份2505324股,支付约4249.89万元